Hindawi Publishing Corporation Disease Markers Volume 2015, Article ID 591454, 7 pages http://dx.doi.org/10.1155/2015/591454
Research Article The Apolipoprotein B/Apolipoprotein A-I Ratio as a Potential Marker of Plasma Atherogenicity Anastasiya M. Kaneva,1 Natalya N. Potolitsyna,1 Evgeny R. Bojko,1 and Jon Ø. Odland2 1
Institute of Physiology, Komi Science Center, Ural Branch of Russian Academy of Sciences, Pervomaiskaya Avenue 50, Syktyvkar 167982, Russia 2 Faculty of Health Sciences, The Arctic University of Norway, 9037 Tromsø, Norway Correspondence should be addressed to Anastasiya M. Kaneva; [email protected] Received 25 November 2014; Revised 18 February 2015; Accepted 25 February 2015 Academic Editor: Benoit Dugue Copyright © 2015 Anastasiya M. Kaneva et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Background. The apolipoprotein (apo) B/apoA-I ratio represents the balance between apoB-rich atherogenic particles and apoAI-rich antiatherogenic particles, and this ratio is considered to be a marker of cardiovascular risk. Although many studies have demonstrated the importance of the apoB/apoA-I ratio in predicting the presence or absence of cardiovascular disease, less is known about apoB/apoA-I ratio as a marker of plasma atherogenicity. Methods. A total of 157 normolipidemic men aged 20–59 years were included in the study. The plasma levels of total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), apoA-I, apoB, and apoE were determined after a 12 h fasting period. Results. The median of the apoB/apoA-I ratio in the studied normolipidemic subjects was 0.52, with values ranging from 0.19 to 2.60. The percentage of subjects with the apoB/apoA-I ratio exceeding 0.9 (the accepted risk value of cardiovascular disease) was 19.1%. The subjects with apoB/apoA-I>0.9 were characterized by higher TG levels and atherogenic index of plasma (AIP) and lower values of ratio of low-density lipoprotein cholesterol (LDLC) to apoB (LDL-C/apoB) and apoE levels compared with men with apoB/apoA-I
Research Article The Apolipoprotein B/Apolipoprotein A-I Ratio as a Potential Marker of Plasma Atherogenicity Anastasiya M. Kaneva,1 Natalya N. Potolitsyna,1 Evgeny R. Bojko,1 and Jon Ø. Odland2 1
Institute of Physiology, Komi Science Center, Ural Branch of Russian Academy of Sciences, Pervomaiskaya Avenue 50, Syktyvkar 167982, Russia 2 Faculty of Health Sciences, The Arctic University of Norway, 9037 Tromsø, Norway Correspondence should be addressed to Anastasiya M. Kaneva; [email protected] Received 25 November 2014; Revised 18 February 2015; Accepted 25 February 2015 Academic Editor: Benoit Dugue Copyright © 2015 Anastasiya M. Kaneva et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Background. The apolipoprotein (apo) B/apoA-I ratio represents the balance between apoB-rich atherogenic particles and apoAI-rich antiatherogenic particles, and this ratio is considered to be a marker of cardiovascular risk. Although many studies have demonstrated the importance of the apoB/apoA-I ratio in predicting the presence or absence of cardiovascular disease, less is known about apoB/apoA-I ratio as a marker of plasma atherogenicity. Methods. A total of 157 normolipidemic men aged 20–59 years were included in the study. The plasma levels of total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), apoA-I, apoB, and apoE were determined after a 12 h fasting period. Results. The median of the apoB/apoA-I ratio in the studied normolipidemic subjects was 0.52, with values ranging from 0.19 to 2.60. The percentage of subjects with the apoB/apoA-I ratio exceeding 0.9 (the accepted risk value of cardiovascular disease) was 19.1%. The subjects with apoB/apoA-I>0.9 were characterized by higher TG levels and atherogenic index of plasma (AIP) and lower values of ratio of low-density lipoprotein cholesterol (LDLC) to apoB (LDL-C/apoB) and apoE levels compared with men with apoB/apoA-I
